Beta Bionics, Inc announced it raised $57 Million in an initial filing from an offering of $57 Million
Mar 02, 2022•over 3 years ago
Amount Raised
$57 Million
ConcordBiotechnology
Company Information
Company
Beta Bionics
Location
300 Baker Avenue, Suite 301
Concord, Massachusetts, United States
About
Beta Bionics is a commercial stage medical technology company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWDs) by utilizing advanced adaptive algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared autonomous insulin delivery device in the market and offers the potential to substantially improve overall outcomes across broad populations of PWDs.